BSLK

Bolt Projects Holdings, Inc.

OTC · Industrial Organic Chemicals · Inc. DE · CIK 0001841125
$0.0600 -6.25%
Vol
Inst. Holders2 funds
Inst. Value$35.7K
Inst. Activity1 buys / 0 sells
SEC Reports1
Exchange OTC·Sector Industrial Organic Chemicals·Inc. DE·CIK 0001841125·Prev Close $0.0640

Recent Activity

Mar 12, 2026 SEC
Bolt Projects Holdings, Inc. (BSLKW) has had five separate registration statements (Form S-1 or S-3) declared effective
EFFECT — Impact 5/10
Feb 9, 2026 Insider
Slattery Paul Joseph sold 21,115 shares
GENERAL COUNSEL & SECRETARY @ $0.00 ($0.00)
Feb 9, 2026 Insider
Breslauer David Nate sold 46,335 shares
CHIEF TECHNOLOGY OFFICER @ $0.00 ($0.00)
Feb 9, 2026 Insider
Widmaier Daniel Matthew sold 46,335 shares
CHIEF EXECUTIVE OFFICER @ $0.00 ($0.00)
Inst.
VANGUARD GROUP INC — DOUBLED
44,134 shares ($35.3K)
Inst.
VANGUARD GROUP INC — NEW
16,510 shares ($62.4K)

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$35.3KDOUBLED
BANK OF AMERICA CORP$431.00

Recent Insider Trades

DateInsiderTypeValue
Feb 9, 2026Slattery PaulA$0.00
Feb 9, 2026Breslauer DavidA$0.00
Feb 9, 2026Widmaier DanielA$0.00
2 institutional holders with $35.7K total value (44,672 shares) as of 2025-Q4. Top holders: VANGUARD, BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC44,134$35.3K98.8%DOUBLED +167.3%
2BANK OF AMERICA CORP /DE/538$431.001.2%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
VANGUARD GROUP INCDOUBLED16,51044,134+167.3%$35.3K2025-Q4
VANGUARD GROUP INCNEW16,510$62.4K2025-Q3
UBS Group AGNEAR_EXIT20,72417-99.9%$64.002025-Q3
UBS Group AGNEW20,724$58.4K2025-Q2
FMR LLCEXIT57,5770-100.0%$0.002025-Q2
MORGAN STANLEYEXIT40,0000-100.0%$0.002025-Q2
VANGUARD GROUP INCEXIT66,3470-100.0%$0.002025-Q2
UBS Group AGEXIT38,9100-100.0%$0.002025-Q2
VANGUARD GROUP INCNEW66,347$20.4K2025-Q1
MORGAN STANLEYNEW40,000$12.3K2025-Q1
UBS Group AGADD27,19338,910+43.1%$11.9K2025-Q1
WELLS FARGO & COMPANY/MNDOUBLED7,00015,000+114.3%$4.6K2025-Q1
UBS Group AGADD21,37227,193+27.2%$13.1K2024-Q4
3 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Feb 9, 2026Slattery Paul JosephGENERAL COUNSEL & SECRETARYA21,115$0.00$0.00
Feb 9, 2026Breslauer David NateCHIEF TECHNOLOGY OFFICERA46,335$0.00$0.00
Feb 9, 2026Widmaier Daniel MatthewCHIEF EXECUTIVE OFFICERA46,335$0.00$0.00
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.0/10.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.